Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Macrogenics Inc (NASDAQ: MGNX) closed at $3.41 in the last session, up 2.10% from day before closing price of $3.34. In other words, the price has increased by $2.10 from its previous closing price. On the day, 0.52 million shares were traded. MGNX stock price reached its highest trading level at $3.485 during the session, while it also had its lowest trading level at $3.245.
Ratios:
We take a closer look at MGNX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.69 and its Current Ratio is at 3.75. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.24.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 04 ’24 when Peters Jeffrey Stuart sold 51,395 shares for $15.55 per share. The transaction valued at 799,148 led to the insider holds 0 shares of the business.
Peters Jeffrey Stuart sold 19,625 shares of MGNX for $421,938 on Mar 06 ’24. The Senior VP and General Counsel now owns 8,895 shares after completing the transaction at $21.50 per share. On Mar 04 ’24, another insider, Risser Eric Blasius, who serves as the Chief Operating Officer of the company, sold 41,159 shares for $19.76 each. As a result, the insider received 813,501 and left with 38,900 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MGNX now has a Market Capitalization of 214023200 and an Enterprise Value of 47760356. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.51 while its Price-to-Book (P/B) ratio in mrq is 1.78. Its current Enterprise Value per Revenue stands at 0.338 whereas that against EBITDA is -0.479.
Stock Price History:
The Beta on a monthly basis for MGNX is 2.03, which has changed by -0.64124596 over the last 52 weeks, in comparison to a change of 0.27870452 over the same period for the S&P500. Over the past 52 weeks, MGNX has reached a high of $21.88, while it has fallen to a 52-week low of $2.95. The 50-Day Moving Average of the stock is -7.78%, while the 200-Day Moving Average is calculated to be -52.10%.
Shares Statistics:
According to the various share statistics, MGNX traded on average about 606.74K shares per day over the past 3-months and 464820 shares per day over the past 10 days. A total of 62.76M shares are outstanding, with a floating share count of 57.89M. Insiders hold about 7.77% of the company’s shares, while institutions hold 84.43% stake in the company. Shares short for MGNX as of 1732838400 were 5214021 with a Short Ratio of 8.59, compared to 1730332800 on 5457556. Therefore, it implies a Short% of Shares Outstanding of 5214021 and a Short% of Float of 10.190000000000001.
